LFCR
Lifecore Biomedical Inc.
NASDAQ: LFCR · HEALTHCARE · DRUG MANUFACTURERS - SPECIALTY & GENERIC
$5.07
+2.63% today
Updated 2026-04-30
Market cap
$190.38M
P/E ratio
—
P/S ratio
1.47x
EPS (TTM)
$-1.27
Dividend yield
—
52W range
$4 – $9
Volume
0.4M
Lifecore Biomedical Inc. (LFCR) Financial statements
SEC filings — annual and quarterly data.
Income statement — annual
| Item | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $231.95M | $210.50M | $238.53M | $235.94M | $238.22M | $276.73M | $317.55M | $441.71M | $476.81M | $539.26M | $541.10M | $532.26M | $524.23M | $557.56M | $160.07M | $100.87M | $185.79M | $111.27M | $128.26M | $128.87M |
| Revenue growth (YoY) | — | -9.2% | +13.3% | -1.1% | +1.0% | +16.2% | +14.8% | +39.1% | +7.9% | +13.1% | +0.3% | -1.6% | -1.5% | +6.4% | -71.3% | -37.0% | +84.2% | -40.1% | +15.3% | +0.5% |
| Cost of revenue | $191.91M | $178.11M | $200.30M | $201.66M | $204.46M | $230.03M | $265.41M | $378.95M | $414.25M | $473.85M | $470.14M | $449.07M | $445.89M | $476.56M | $120.68M | $61.94M | $135.42M | $72.20M | $86.41M | $88.57M |
| Gross profit | $40.04M | $32.39M | $38.23M | $34.28M | $33.77M | $46.70M | $52.14M | $62.76M | $62.56M | $65.41M | $70.96M | $83.19M | $78.34M | $81.00M | $39.39M | $38.94M | $50.37M | $39.07M | $41.85M | $40.30M |
| Gross margin | 17.3% | 15.4% | 16.0% | 14.5% | 14.2% | 16.9% | 16.4% | 14.2% | 13.1% | 12.1% | 13.1% | 15.6% | 14.9% | 14.5% | 24.6% | 38.6% | 27.1% | 35.1% | 32.6% | 31.3% |
| R&D | $3.04M | $3.07M | $3.25M | $3.67M | $4.36M | $9.28M | $9.63M | $9.29M | $7.20M | $6.99M | $7.23M | $9.47M | $12.80M | $11.47M | $7.58M | $6.68M | $7.84M | $7.84M | $8.57M | $8.26M |
| SG&A | — | — | — | — | — | — | — | — | $34.72M | — | $47.41M | $56.31M | $50.55M | $62.76M | $72.09M | $65.26M | $46.13M | $42.43M | $43.01M | $44.05M |
| Operating income | $9.02M | $30.36M | $15.18M | $12.60M | $11.71M | $8.03M | $14.58M | $24.87M | $20.19M | $18.46M | $-19.79M | $15.51M | $11.85M | $-8.01M | $-25.88M | $-8.82M | $-3.60M | $-11.79M | $-8.84M | $-17.25M |
| Operating margin | 3.9% | 14.4% | 6.4% | 5.3% | 4.9% | 2.9% | 4.6% | 5.6% | 4.2% | 3.4% | -3.7% | 2.9% | 2.3% | -1.4% | -16.2% | -8.7% | -1.9% | -10.6% | -6.9% | -13.4% |
| EBITDA | $12.23M | $33.63M | $18.38M | $17.04M | $12.24M | $14.57M | $26.99M | $41.57M | $38.69M | $30.39M | $-7.80M | $26.68M | $24.99M | $23.47M | $-7.16M | $-987000.00 | $-68.03M | $12.84M | $35.60M | $-8.81M |
| EBITDA margin | 5.3% | 16.0% | 7.7% | 7.2% | 5.1% | 5.3% | 8.5% | 9.4% | 8.1% | 5.6% | -1.4% | 5.0% | 4.8% | 4.2% | -4.5% | -1.0% | -36.6% | 11.5% | 27.8% | -6.8% |
| EBIT | $9.02M | $30.36M | $15.18M | $13.90M | $8.88M | $9.26M | $21.37M | $34.27M | $31.57M | $23.30M | $-16.86M | $16.00M | $13.02M | $8.87M | $-26.00M | $-20.85M | $-85.91M | $-5.22M | $27.60M | $-16.84M |
| Interest expense | $24000.00 | $23.95M | $1.72M | $8000.00 | $88000.00 | $820000.00 | $929000.00 | $2.01M | $1.65M | $1.83M | $1.99M | $1.83M | $1.95M | $5.23M | $4.65M | $8.93M | $17.36M | $15.55M | $18.09M | $21.84M |
| Income tax | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Effective tax rate | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Net income | $8.65M | $29.19M | $13.54M | $7.73M | $3.98M | $3.92M | $12.70M | $22.59M | $19.14M | $13.54M | $-11.64M | $10.59M | $24.83M | $2.12M | $-38.19M | $-32.29M | $-97.43M | $-116.72M | $12.01M | $-38.72M |
| Net income growth (YoY) | — | +237.4% | -53.6% | -42.9% | -48.5% | -1.6% | +223.9% | +77.9% | -15.2% | -29.3% | -185.9% | +191.0% | +134.5% | -91.5% | -1899.8% | +15.4% | -201.7% | -19.8% | +110.3% | -422.3% |
| Profit margin | 3.7% | 13.9% | 5.7% | 3.3% | 1.7% | 1.4% | 4.0% | 5.1% | 4.0% | 2.5% | -2.2% | 2.0% | 4.7% | 0.4% | -23.9% | -32.0% | -52.4% | -104.9% | 9.4% | -30.0% |